Top 12 Fairmount Funds Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| DMRA | DAMORA THERAPEUTICS INC | 16.3% | 8.71M | $225.7M | new | $24.45(+22.59%) | 2026-03-31 | |
| DNTH | DIANTHUS THERAPEUTICS INC | 15.38% | 2.54M | $212.9M | +18.72%(+400.00K) | $24.72(+281.59%) | 2026-03-31 | |
| COGT | COGENT BIOSCIENCES INC | 15.3% | 5.50M | $211.8M | -38.87%(-3.50M) | $9.28(+317.12%) | 2026-03-31 | |
| SYRE | SPYRE THERAPEUTICS INC | 14.64% | 4.02M | $202.7M | +0.00%(+0) | $28.70(+201.84%) | 2026-03-31 | |
| ORKA | ORUKA THERAPEUTICS INC | 13.13% | 3.71M | $181.7M | +0.00%(+0) | $32.86(+159.31%) | 2026-03-31 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 5.53% | 3.91M | $76.6M | +0.00%(+0) | $18.73(+3.55%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 5.25% | 1.86M | $72.7M | -50.00%(-1.86M) | $18.45(+169.99%) | 2026-03-31 | |
| JBIO | JADE BIOSCIENCES INC | 4.62% | 4.55M | $64.0M | +0.00%(+0) | $38.37(-43.94%) | 2026-03-31 | |
| CBIO | CRESCENT BIOPHARMA INC. | 3.65% | 2.75M | $50.5M | +0.00%(+0) | $15.51(+10.19%) | 2026-03-31 | |
| ZBIO | ZENAS BIOPHARMA INC | 3.33% | 2.36M | $46.1M | +6.79%(+150.00K) | $19.27(-4.84%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +51.76% | +249.50% |
| Top 20 Holdings Unweighted | +52.04% | +251.49% |
Sign up free to track Fairmount Funds Management LLC, compare funds side by side, and get alerts the moment positions change.